Ligand Pharma (LGND) Tops Q2 EPS by 141c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Ligand Pharma (LGND) Tops Q2 EPS by 141c

Ligand Reports Second Quarter 2015 Financial Results

August 4, 2015 4:00 PM EDT

Conference Call Begins at 4:30 p.m. Eastern Time Today

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and six months ended June 30, 2015, and provided an operating forecast and program updates.

Financial highlights for the second quarter of 2015 include:

Total revenues were $18.4 million and royalty revenues were $6.6 million, an increase of 74% and 26%, respectively, compared with the second quarter of 2014. Adjusted EPS was $1.81 and GAAP EPS was $1.11. The company generated operating cash of... More